Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Edwards Lifesciences (EW) SAPIEN 3 Approved 4 Months Ahead of Schedule; Canaccord Genuity Reiterates Buy
-
Synergy (SGYP) PT Lifted to $19 at Canaccord Genuity; 'This Thang Don't Stank'
-
Pre-Open Stock Movers 06/18: (LMNS) (DGLY) (BMRN) Higher; (HERO) (RATE) (ORCL) Lower (more...)
-
Canaccord Genuity Upgrades Colgate-Palmolive Company (CL) to Hold
-
UPDATE: Canaccord Genuity Starts Pacific DataVision (PDVW) at Buy
-
Canaccord Genuity Raises Price Target on Castlight Health (CSLT) Following Analyst and Investor Summit
-
Canaccord Genuity Reiterates Buy on Trupanion (TRUP) Following Investor Meetings
-
Canaccord Genuity Maintains Buy on Stryker Corp. (SYK) Following Analyst Event
-
Canaccord Genuity Raises Price Target on Synergy Resources (SYRG) as they Prepare for a Second Wattenberg Rig
-
Seres Therapeutics (MCRB) Sees IPO Price of $15 - $17/Share
-
vTv Therapeutics Files Registration Statement for Proposed Initial Public Offering
-
vTv Therapeutics (VTVT) Files for $172.5M IPO
-
Notable Analyst Rating Changes 6/15: (JBL) (PBR) (LOW) Upgraded; (EMC) (MU) (TDC) Downgraded
-
Agios Pharma (AGIO) PT Lowered to $93 at Canaccord Genuity on AG-120 Solid Tumor Concerns
-
Canaccord Genuity Believes Amazon.com (AMZN) is Still in Investment mode But Raises Price Target to $400; Reiterates Hold
-
Canaccord Genuity Starts BCE (BCE) at Hold
-
UPDATE: Notable Analyst Rating Changes 6/12: (UDR) (CTXS) (DLR) Upgraded; (GMCR) (STE) (MJN) Downgraded
-
UPDATE: Canaccord Genuity Upgrades ARC Group Worldwide (ARCW) to Buy
-
UPDATE: Canaccord Genuity Upgrades Digital Realty Trust (DLR) to Buy
-
North American Financial 15 Split Corp. Completes Overnight Offering of $25,737,000
-
EMED Mining Public Limited: Results of Placing Placing to RAISE £ 6.8 Million (US$10.5 Million)
-
Vernalis Announces CCP-07 Starts 12 Month Stability Testing
-
Canaccord Genuity Remains Bullish on Emerald Oil (EOX) Following Failed Acquisition and Equity Raise
-
Canaccord Genuity Maintains Hold on Box (BOX) Ahead of Q1 Results
-
Canaccord Genuity Cuts Price Target on United Natural Foods (UNFI) Following Q3 Results
-
Intersect ENT Announces Exercise of Underwriters’ Option and the Closing of Its Public Offering
-
Streetinsider.com's Hot Lunchtime Reads 6/8: (TSLA) (GOOG) (FINL) (AAL)
-
UPDATE: Canaccord Genuity Upgrades Finish Line (FINL) to Buy
-
Notable Analyst Rating Changes 6/8: (FINL) (MON) (INVN) Upgraded; (UAL) (OC) (RIO) Downgraded
-
Canaccord Genuity Maintains Hold Rating Ahead of lululemon athletica (LULU) Q1 Results
-
Canaccord Genuity Cuts Price Target on Sierra Wireless (SWIR) Following Investor Meeting
-
Canaccord Genuity Raised Price Target After Meeting with Cavium (CAVM) CEO
-
Minera IRL Announces US$70 Million Bridge Loan and Mandate Letter for Up to US$240 Million for Ollachea Project Financing
-
Amana Copper Ltd. Announces Transaction With International Wastewater Systems
-
Vertex Pharma (VRTX) to Collaborate with Parion on ENaC Inhibitors; Canaccord Genuity Maintains Buy
-
Ultragenyx Pharma (RARE) PT Raised to $97 at Canaccord Genuity
-
Canaccord Genuity Raised Price Target on Cyberonics (CYBX) Ahead of Sorin Group Merger
-
UPDATE: Palatin Technologies' (PTN) Price Target Raised to $6 at Canaccord Genuity Amid Flibanserin FDA Panel Backing
-
Canaccord Genuity Maintains Buy on Mentor Graphics (MENT) Ahead of Meetings
-
Intersect ENT (XENT) Prices Larger 3.58M Common Offering at $25/Share
-
Canaccord Genuity Reiterates Buy on Derma Sciences (DSCI) Believing Timeline Confusion Created Buying Opportunity
-
Ambarella (AMBA) PT Raised to $115 at Canaccord Genuity
-
Cowen Expands Energy Equity Research Team with Addition of Ryan Oatman
-
Intersect ENT Announces Upsizing and Pricing of Public Offering
-
Canaccord Genuity Group Inc. Reports Record Annual Revenue for 2015
-
Nighthawk Energy plc ("Nighthawk" or "the Company") Final Results for the year ended 31 December 2014
-
Canaccord Genuity Raises Price Target on TTM Technologies (TTMI) Following Viasystems Acquisition
-
UPDATE: Canaccord Genuity Starts HTG Molecular Diagnostics (HTGM) at Buy
-
Canaccord Genuity Maintains Bullish View on Alnylam (ALNY) Amid Positive KOL Insights on ALN-CC5
-
Enterprise Mobility Leader Globo Begins Trading on the OTCQX International Exchange in the U.S.


